CIBINQO (abrocitinib) is an oral JAK inhibitor for the treatment of moderate to severe atopic dermatitis (AD). CIBINQO launched in the US in 2022 and has blockbuster potential over the LRF. The US CIBINQO HCP & Messaging Lead is an exciting opportunity for the right marketer to join a talented, agile, and innovative marketing team. The CIBINQO HCP & Messaging Lead is a critical role on the team, leading all US HCP tactics, messaging evolution strategy, field force engagements, and tactical execution. The colleague will formally manage a team of 4 direct reports in addition to working closely with global, cross-functional, and agency partners to maximize growth of the brand. The ideal candidate will have significant US HCP marketing experience, including launch and immediate post-launch experience. He/she should also have a proven track record of delivering business performance in competitive environments and leading through complexity. People management experience is preferred, but not required. The role reports to the US CIBINQO Lead and will interface closely with various members of the Dermatology franchise and LT.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior